TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.81
0.04 (2.26%)
At close: Aug 14, 2025, 3:59 PM
1.90
4.97%
Pre-market: Aug 15, 2025, 08:09 AM EDT
TScan Therapeutics Fail-to-Deliver
Total FTD Shares
6.23K
Below Average
FTD / Avg. Volume
1.09%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 8, 2025,
TScan Therapeutics Inc. has
6,227
shares failed to deliver, representing 1.09%
of the average daily volume of
572,759
shares. Over the past year, the monthly average FTD is
3,658
shares, with the current level 70% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 08, 2025 | 1.7 | 6.23K | +93.15% |
| Jun 26, 2025 | 1.48 | 3.22K | -12.44% |
| May 29, 2025 | 1.47 | 3.68K | -38.91% |
| Apr 29, 2025 | 1.59 | 6.03K | +240.89% |
| Mar 26, 2025 | 1.45 | 1.77K | +1668.00% |
| Feb 28, 2025 | 2.1 | 100 | -85.21% |
| Jan 31, 2025 | 2.57 | 676 | +2716.67% |
| Dec 18, 2024 | 2.9 | 24 | -96.17% |
| Oct 28, 2024 | 4.89 | 627 | +90.00% |
| Sep 23, 2024 | 5.2 | 330 | -96.55% |
| Aug 16, 2024 | 5.74 | 9.56K | +7087.97% |
| Jul 26, 2024 | 7.27 | 133 | -88.63% |
| Jun 25, 2024 | 6.19 | 1.17K | +266.77% |
| May 31, 2024 | 8.55 | 319 | -88.28% |
| Apr 29, 2024 | 7.68 | 2.72K | -36.00% |
| Mar 26, 2024 | 7.99 | 4.25K | -4.45% |
| Feb 29, 2024 | 6.75 | 4.45K | +178.14% |
| Jan 24, 2024 | 4.89 | 1.6K | -38.68% |
| Dec 19, 2023 | 4.9 | 2.61K | +26.14% |
| Nov 30, 2023 | 6.53 | 2.07K | +92.74% |
| Oct 30, 2023 | 4.02 | 1.07K | -78.76% |
| Sep 28, 2023 | 2.62 | 5.06K | +5007.07% |
| Aug 14, 2023 | 2.13 | 99 | +120.00% |
| Jul 28, 2023 | 2.11 | 45 | +2150.00% |
| Jun 30, 2023 | 2.5 | 2 | -99.99% |
| May 31, 2023 | 2.3 | 15.81K | +105306.67% |
| Apr 26, 2023 | 2.32 | 15 | -57.14% |
| Mar 23, 2023 | 2.45 | 35 | -98.97% |
| Feb 28, 2023 | 2.95 | 3.41K | +213.31% |
| Jan 31, 2023 | 1.82 | 1.09K | n/a |